{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:45:50Z","timestamp":1786373150596,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>\n                      Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow and is a potential cause of chronic kidney injury, yet little is known regarding inflammatory pathways in this disorder in human participants. This study aimed to examine the hypothesis that reduced renal blood flow (RBF) in ARAS would be associated with tissue TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      activation and inflammatory cell accumulation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>\n                      This cross-sectional study of ARAS of varying severity compared transjugular biopsy specimens in patients with ARAS (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =12, recruited between 2008 and 2012) with tissue from healthy kidney donors (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =15) and nephrectomy specimens from individuals with total vascular occlusion (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =65). ARAS patients were studied under controlled conditions to measure RBF by multidetector computed tomography and tissue oxygenation by blood oxygen level\u2013dependent magnetic resonance imaging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the nonstenotic contralateral kidneys, RBF was reduced in poststenotic kidneys (242\u00b1149 versus 365+174 ml\/min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01) as was single-kidney GFR (28\u00b117 versus 41\u00b119 ml\/min;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01), whereas cortical and medullary oxygenation were relatively preserved. Tissue TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      immunoreactivity was higher in ARAS patients compared with those with both normal kidneys and those with total occlusion (mean score 2.4\u00b10.7 versus 1.5+1.1 in the nephrectomy group and versus 0\u00b10 in donors;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.01). By contrast, the number of CD68+ macrophages was higher with greater disease severity (from 2.2\u00b12.7 in normal to 22.4\u00b118 cells\/high-power field in nephrectomy samples;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The results of this study indicate robust stimulation of TGF-\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      associated with macrophage infiltration within the human kidney with vascular occlusive disease.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.06460612","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T03:59:35Z","timestamp":1356062375000},"page":"546-553","source":"Crossref","is-referenced-by-count":62,"title":["TGF Expression and Macrophage Accumulation in Atherosclerotic Renal Artery Stenosis"],"prefix":"10.2215","volume":"8","author":[{"given":"Monika L.","family":"Gloviczki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira T.","family":"Keddis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna D.","family":"Garovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"McKusick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Textor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20230811","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajh.2010.174","article-title":"Renovascular hypertension and ischemic nephropathy.","volume":"23","author":"Textor","year":"2010","journal-title":"Am J Hypertens"},{"key":"R2-8-20230811","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","article-title":"Revascularization versus medical therapy for renal-artery stenosis.","volume":"361","author":"Wheatley","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-8-20230811","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1523-1755.2004.00353.x","article-title":"Delay of dialysis in end-stage renal failure: Prospective study on percutaneous renal artery interventions.","volume":"65","author":"Korsakas","year":"2004","journal-title":"Kidney Int"},{"key":"R4-8-20230811","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCULATIONAHA.106.637751","article-title":"Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001.","volume":"115","author":"Guo","year":"2007","journal-title":"Circulation"},{"key":"R5-8-20230811","first-page":"2","article-title":"The natural history of renal artery stenosis: Who should be evaluated for suspected ischemic nephropathy?","volume":"16","author":"Greco","year":"1996","journal-title":"Semin Nephrol"},{"key":"R6-8-20230811","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1046\/j.1523-1755.2000.07509.x","article-title":"The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease.","volume":"75","author":"Klahr","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"R7-8-20230811","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis.","volume":"78","author":"Lee","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"R8-8-20230811","doi-asserted-by":"crossref","first-page":"F1055","DOI":"10.1152\/ajprenal.90439.2008","article-title":"Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension.","volume":"297","author":"Cheng","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"R9-8-20230811","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1161\/01.ATV.0000077477.40824.52","article-title":"Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.","volume":"23","author":"Chade","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-8-20230811","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/HYPERTENSIONAHA.109.145227","article-title":"Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.","volume":"55","author":"Gloviczki","year":"2010","journal-title":"Hypertension"},{"key":"R11-8-20230811","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.ki.5001799","article-title":"Glomerular volume and renal histology in obese and non-obese living kidney donors.","volume":"70","author":"Rea","year":"2006","journal-title":"Kidney Int"},{"key":"R12-8-20230811","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/ndt\/gfq269","article-title":"Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: Clinical and histopathological correlates.","volume":"25","author":"Keddis","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R13-8-20230811","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R14-8-20230811","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/RLI.0b013e3181b4c1e8","article-title":"Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease.","volume":"44","author":"Gloviczki","year":"2009","journal-title":"Invest Radiol"},{"key":"R15-8-20230811","doi-asserted-by":"crossref","first-page":"F630","DOI":"10.1152\/ajprenal.2001.281.4.F630","article-title":"Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function.","volume":"281","author":"Krier","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R16-8-20230811","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.rcl.2010.02.005","article-title":"CT angiography of the renal circulation.","volume":"48","author":"Liu","year":"2010","journal-title":"Radiol Clin North Am"},{"key":"R17-8-20230811","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1118\/1.2938729","article-title":"Using flow information to support 3D vessel reconstruction from rotational angiography.","volume":"35","author":"Waechter","year":"2008","journal-title":"Med Phys"},{"key":"R18-8-20230811","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1152\/ajpregu.00602.2001","article-title":"Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs.","volume":"283","author":"Krier","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R19-8-20230811","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1053\/snep.2001.26795","article-title":"Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases.","volume":"21","author":"Border","year":"2001","journal-title":"Semin Nephrol"},{"key":"R21-8-20230811","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/360361a0","article-title":"Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.","volume":"360","author":"Border","year":"1992","journal-title":"Nature"},{"key":"R22-8-20230811","first-page":"S34","article-title":"Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.","volume":"51","author":"Ziyadeh","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"R23-8-20230811","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ki.2010.516","article-title":"Myofibroblast differentiation during fibrosis: Role of NAD(P)H oxidases.","volume":"79","author":"Barnes","year":"2011","journal-title":"Kidney Int"},{"key":"R24-8-20230811","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0959-9673.2004.00377.x","article-title":"Smad3 as a mediator of the fibrotic response.","volume":"85","author":"Flanders","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"R25-8-20230811","first-page":"F829","article-title":"The emerging role of transforming growth factor-beta in kidney diseases.","volume":"266","author":"Sharma","year":"1994","journal-title":"Am J Physiol"},{"key":"R26-8-20230811","doi-asserted-by":"crossref","first-page":"F1455","DOI":"10.1152\/ajprenal.00645.2011","article-title":"Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension.","volume":"302","author":"Warner","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R27-8-20230811","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3181\/00379727-214-44066","article-title":"Role of transforming growth factor-beta in tissue injury and repair.","volume":"214","author":"Grande","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"R28-8-20230811","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1073\/pnas.83.15.5531","article-title":"BSC-1 growth inhibitor\/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.","volume":"83","author":"Ristow","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-8-20230811","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.semnephrol.2010.03.005","article-title":"Macrophages, dendritic cells, and kidney ischemia-reperfusion injury.","volume":"30","author":"Li","year":"2010","journal-title":"Semin Nephrol"},{"key":"R30-8-20230811","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis.","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"R31-8-20230811","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair.","volume":"22","author":"Lee","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R32-8-20230811","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: An asset for the resolution of inflammation.","volume":"142","author":"Porcheray","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R33-8-20230811","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.2010030269","article-title":"Macrophages in renal disease.","volume":"22","author":"Wang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R34-8-20230811","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/HYPERTENSIONAHA.111.171405","article-title":"Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease.","volume":"58","author":"Gloviczki","year":"2011","journal-title":"Hypertension"},{"key":"R35-8-20230811","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcin.2008.12.008","article-title":"The uncertain value of renal artery interventions: Where are we now?","volume":"2","author":"Textor","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"R36-8-20230811","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/HJH.0b013e32833510e5","article-title":"Screening renal artery angiography in hypertensive patients undergoing coronary angiography and 6-month follow-up after ad hoc percutaneous revascularization.","volume":"28","author":"Rimoldi","year":"2010","journal-title":"J Hypertens"},{"key":"R37-8-20230811","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.med.52.1.421","article-title":"Renal artery stenosis: A common, treatable cause of renal failure?","volume":"52","author":"Textor","year":"2001","journal-title":"Annu Rev Med"},{"key":"R38-8-20230811","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-5347(17)52453-2","article-title":"Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease.","volume":"129","author":"Novick","year":"1983","journal-title":"J Urol"},{"key":"R39-8-20230811","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1525-139X.2001.00039.x","article-title":"How important is atheromatous renal artery stenosis as a cause of end-stage renal disease?","volume":"14","author":"Main","year":"2001","journal-title":"Semin Dial"},{"key":"R40-8-20230811","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCULATIONAHA.108.788653","article-title":"Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.","volume":"119","author":"Chade","year":"2009","journal-title":"Circulation"},{"key":"R41-8-20230811","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/stem.1047","article-title":"Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis.","volume":"30","author":"Eirin","year":"2012","journal-title":"Stem Cells"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201304000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:42:54Z","timestamp":1786369374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201304000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06460612","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}